TDAC and ProLogium Advance Merger with SEC Filing

Translational Development Acquisition Company (TDAC) announced on Thursday that ProLogium has filed its initial F-4 registration statement with the U.S. Securities and Exchange Commission (SEC). This filing marks a significant step forward in the companies' planned business combination.

The F-4 filing by ProLogium is a requirement for the proposed de-SPAC transaction, a process where a private company combines with a publicly traded special purpose acquisition company (SPAC). The submission enables the SEC to review the details of the transaction.

Specific terms or the timeline for the completion of the merger have not yet been disclosed. The transaction is expected to support ProLogium's growth initiatives within the battery manufacturing sector.

TDAC is a SPAC, a type of shell company with no commercial operations, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. ProLogium is a battery manufacturer.